Pancreas transplantation with grafts obtained from donation after cardiac death or donation after brain death results in comparable outcomes.

delayed graft function (DGF) donation after brain death (DBD) donation after cardiac death (DCD) pancreas after kidney transplant (PAK) pancreas transplant alone (PTA) pancreas transplantation simultaneous kidney and pancreas transplant (SPK)

Journal

Frontiers in transplantation
ISSN: 2813-2440
Titre abrégé: Front Transplant
Pays: Switzerland
ID NLM: 9918573988006676

Informations de publication

Date de publication:
2023
Historique:
received: 28 02 2023
accepted: 21 07 2023
medline: 12 7 2024
pubmed: 12 7 2024
entrez: 12 7 2024
Statut: epublish

Résumé

Pancreas organ shortages and long recipient waitlist times are critical components that limit recipients from receiving a pancreas transplant. Over the last decade, our center has been using donation after cardiac death (DCD) donors as an adjunct to donation after brain death (DBD) donors to expand the organ pool. The aim of this study was to compare recipient and graft survival between DCD and DBD recipients. A retrospective single center propensity matched analysis (2011-2020) of 32 DCD vs 96 DBD pancreas transplants was performed. 8-year recipient survival was similar between DCD and DBD groups (87.4% vs 92.7%, Recipients of DCD grafts demonstrate equivalent long-term patient and graft survival compared to DBD recipients for pancreas transplantation. Increased utilization of well selected DCD donors is a safe strategy to increase the donor pool.

Identifiants

pubmed: 38993888
doi: 10.3389/frtra.2023.1176398
pmc: PMC11235253
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1176398

Informations de copyright

© 2023 Bleszynski, Parmentier, Torres-Hernandez, Ray, Yousuf, Norgate, Schiff, Shwaartz, Sapisochin, McGilvray, Selzner and Reichman.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Michael S Bleszynski (MS)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Catherine Parmentier (C)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Alejandro Torres-Hernandez (A)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Samrat Ray (S)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Anila Yousuf (A)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Andrea Norgate (A)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Jeffrey Schiff (J)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Chaya Shwaartz (C)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Gonzalo Sapisochin (G)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Ian McGilvray (I)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Markus Selzner (M)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Trevor W Reichman (TW)

Ajmera Transplant Centre, Toronto General Hospital, Toronto, ON, Canada.

Classifications MeSH